Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Shenzhen Lifotronic Technology Co OCF Margin %?
Shenzhen Lifotronic Technology CoSHSE:688389 -0.85%89 OCF Margin % is 9.30% as of Mar. 2026, which is 63% below its 10-year median of 24.86. GuruFocus rates SHSE:688389 with a GF Score™ of 89/100 and a GF Value™ of ¥15.69 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Shenzhen Lifotronic Technology Co ranks better than 91.17% on this metric.
The historical rank and industry rank for Shenzhen Lifotronic Technology Co's OCF Margin % or its related term are showing as below:
SHSE:688389'
s OCF Margin % Range Over the Past 10 Years
Min: 14.05 Med: 24.86 Max: 27.64
Current: 28.26
During the past 10 years, the highest OCF Margin % of Shenzhen Lifotronic Technology Co was 27.64%. The lowest was 14.05%. And the median was 24.86%.
SHSE:688389's OCF Margin % is ranked better than 91.17% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.82
vs SHSE:688389: 28.26
Shenzhen Lifotronic Technology Co OCF Margin % Related Terms
Shenzhen Lifotronic Technology Co OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Lifotronic Technology Co OCF Margin % Chart
SHSE:688389 vs ABT, SYK, MDT: OCF Margin % Comparison
For the Medical Devices subindustry, Shenzhen Lifotronic Technology Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shenzhen Lifotronic Technology Co OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shenzhen Lifotronic Technology Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Shenzhen Lifotronic Technology Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shenzhen Lifotronic Technology Co (SHSE:688389) has a OCF Margin % of 9.30% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Shenzhen Lifotronic Technology Co and its competitors. This is 63% below median its historical median of 24.86. Over the past decade, Shenzhen Lifotronic Technology Co's OCF Margin % has ranged from 14.05 to 27.64. According to the industry distribution chart, Shenzhen Lifotronic Technology Co ranks #72 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 8.8%.
Is Shenzhen Lifotronic Technology Co's OCF Margin % too high?
Shenzhen Lifotronic Technology Co's current OCF Margin % of 9.30% is 63% below median its 10-year median of 24.86. Over the past 10 years, this metric has ranged from a low of 14.05 to a high of 27.64. The Medical Devices & Instruments industry median OCF Margin % is 5.82. Shenzhen Lifotronic Technology Co's value of 9.30% is 59.8% above this industry median. Based on the distribution chart, Shenzhen Lifotronic Technology Co ranks #72 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shenzhen Lifotronic Technology Co has a GF Score™ of 89/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shenzhen Lifotronic Technology Co's OCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shenzhen Lifotronic Technology Co ranks #72 out of 815 companies for OCF Margin %. This places Shenzhen Lifotronic Technology Co in the top 9% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 5.82. Shenzhen Lifotronic Technology Co's value of 9.30% is 59.8% above this benchmark. Historically, Shenzhen Lifotronic Technology Co's own OCF Margin % has ranged from 14.05 to 27.64 over the past decade. While the company's 10-year median is 24.86 vs. the industry median of 5.82, Shenzhen Lifotronic Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.82, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shenzhen Lifotronic Technology Co's current OCF Margin % of 9.30% is 59.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Shenzhen Lifotronic Technology Co and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shenzhen Lifotronic Technology Co's current OCF Margin % is 9.30%, which is 63% below median its own 10-year median of 24.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shenzhen Lifotronic Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shenzhen Lifotronic Technology Co (SHSE:688389) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥15.69, compared to a current price of ¥10.48 — trading 33.2% below its estimated fair value. The current OCF Margin % is 9.30%, which is 63% below median its 10-year median of 24.86 and 59.8% above the Medical Devices & Instruments industry median of 5.82. Shenzhen Lifotronic Technology Co's overall GF Score™ is 89/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Shenzhen Lifotronic Technology Co (SHSE:688389), the current OCF Margin % is 9.30% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shenzhen Lifotronic Technology Co (SHSE:688389) Overvalued in 2026?
Based on GuruFocus' analysis, Shenzhen Lifotronic Technology Co stock appears to be undervalued.
The current stock price of ¥10.48 is trading 33.2% below its estimated GF Value™ of ¥15.69.
GuruFocus considers Shenzhen Lifotronic Technology Co to be Significantly Undervalued.
Key valuation signals for SHSE:688389:
OCF Margin %: 9.30% (63% below median its 10-year median of 24.86)
GF Value™: ¥15.69 vs. price of ¥10.48 (33.2% below fair value)
Industry Position: 59.8% above the Medical Devices & Instruments median (#72 of 815)
No single metric tells the full story. See the SHSE:688389 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shenzhen Lifotronic Technology Co Business Description
Shenzhen Lifotronic Technology Co Ltd is a China based company engaged in the development, production and sales of therapeutic and rehabilitation products, in vitro diagnostic equipment and supporting reagents.
89GF Score
Get the complete analysis for SHSE:688389
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688389 has been successfully added to your 
